Testing a new asthma drug in healthy people and those with asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational drug called PRA-216, first in healthy volunteers to check safety, then in people with mild-to-moderate asthma to see if it helps control symptoms. It's an early-stage trial to find out if the drug is safe and works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are generally healthy with no major medical issues.
- You are willing to attend all study visits and follow the rules.
- If you have asthma, you must have been diagnosed at least 1 year ago and currently take daily asthma medication.
- You cannot have smoked or used nicotine products in the last 3 months (or have a history of heavy smoking).
- You cannot have donated blood or plasma in the last 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called PRA-216 in people with COPD. The goal is to see if it is safe and to look at certain markers in the body that might show how the drug works.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
Hear when a new Mild to Moderate Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.